Transplant Education

Understanding the organ transplant process, allocation system, and how to read the data that informs your decisions.

The Transplant Process

How Organ Transplant Works
  1. 1
    Evaluation

    Your medical team refers you to a transplant center where specialists assess whether you are a candidate for transplant. This includes blood work, imaging, cardiac testing, and psychosocial evaluation. The process typically takes several weeks.

  2. 2
    Listing

    Once approved, your transplant center registers you on the national waiting list managed by the United Network for Organ Sharing (UNOS). You can be listed at more than one center simultaneously, known as multiple listing.

  3. 3
    Waiting

    While on the waitlist, your medical team monitors your health and updates your status. Wait times vary dramatically by organ type, blood type, geographic region, and medical urgency. During this time, staying healthy and reachable is critical.

  4. 4
    Transplant

    When a compatible organ becomes available, the transplant team notifies you and the surgery is performed, often within hours. The organ is matched based on medical compatibility, urgency, wait time, and geographic proximity to the donor.

  5. 5
    Recovery

    After surgery, you will spend time in the hospital for monitoring, followed by a structured outpatient recovery. Lifelong immunosuppressive medications are required to prevent rejection. Regular follow-up visits track graft function and overall health.

Allocation & Waitlist

Understanding the Waitlist

Organ allocation in the United States is managed by UNOS under contract with the federal government through the Organ Procurement and Transplantation Network (OPTN). Allocation policies aim to balance medical urgency, fairness, and efficient use of donated organs.

Several factors affect your position and likelihood of receiving an organ:

  • Organ type — Each organ has its own allocation system with different prioritization criteria.
  • Blood type — ABO compatibility between donor and recipient is required. Blood type O patients often wait longest because O organs are compatible with all recipients.
  • Medical urgency — Sicker patients generally receive higher priority, though the specific scoring varies by organ.
  • Time on the waiting list — Accumulated wait time is a factor, especially for kidney allocation.
  • Geographic proximity — Organs are offered first to patients near the donor hospital, then in widening geographic circles. Recent policy changes have shifted toward broader sharing based on distance rather than fixed regions.

Organ-specific scoring systems:

  • MELD (Model for End-Stage Liver Disease) — Used for liver allocation. A score from 6 to 40 based on lab values (bilirubin, INR, creatinine, sodium). Higher scores indicate greater illness severity and higher priority.
  • LAS (Lung Allocation Score) — Used for lung allocation. Combines urgency (expected survival without transplant) and benefit (expected post-transplant survival). Scores range from 0 to 100.
  • cPRA (Calculated Panel Reactive Antibodies) — Used in kidney allocation. Measures how sensitized a patient is to donor antigens. Higher cPRA (0-100%) means fewer compatible donors but also earns additional priority points.

For organ-specific allocation rules and scoring systems, see our Organ Guides.

Key Terms

Key Terms Glossary
UNOS
United Network for Organ Sharing. The private nonprofit that manages the U.S. organ transplant system under federal contract. Maintains the national waiting list and develops allocation policies.
OPTN
Organ Procurement and Transplantation Network. The federal framework established by Congress in 1984 to oversee organ transplantation. UNOS has operated OPTN under contract since its inception.
SRTR
Scientific Registry of Transplant Recipients. Provides statistical analyses of transplant program performance, including wait times, patient and graft survival, and organ offer acceptance rates. Their reports are a key tool for comparing transplant centers.
OPO
Organ Procurement Organization. Regional organizations responsible for coordinating organ donation in their designated service areas. There are 56 OPOs in the United States.
DSA
Donation Service Area. The geographic region served by a single OPO. Historically, organs were first offered within the donor's DSA before expanding to wider regions. Recent policy changes have moved toward distance-based allocation circles.
MELD
Model for End-Stage Liver Disease. A numerical score (6-40) used to prioritize liver transplant candidates based on how urgently they need a transplant. Calculated from bilirubin, INR, creatinine, and sodium lab values.
LAS
Lung Allocation Score. A composite score (0-100) for lung transplant prioritization that balances expected benefit of transplant against urgency of the patient's condition.
cPRA
Calculated Panel Reactive Antibodies. A percentage (0-100%) indicating how sensitized a kidney transplant candidate is to potential donors. Highly sensitized patients (high cPRA) receive additional allocation priority to offset their smaller compatible donor pool.
DCD
Donation after Circulatory Death. Organ donation that occurs after cardiac death rather than brain death. DCD donors are an increasing source of transplantable organs, though with some differences in organ viability compared to brain-dead donors.
HCV+
Hepatitis C Virus Positive. Refers to donors who test positive for hepatitis C. Advances in direct-acting antiviral treatments have made HCV+ organs viable for many recipients, expanding the donor pool significantly.
Graft Survival
The length of time a transplanted organ continues to function after transplant. Measured at standard intervals (1-year, 3-year, 5-year). A key outcome metric for comparing transplant center performance.
Waitlist Mortality
The rate at which patients die while waiting for a transplant. A critical metric for understanding the gap between organ supply and demand, and for evaluating regional differences in access.

Have questions about these terms? See our FAQ for detailed explanations.

Official Resources

Authoritative Data Sources & Patient Information

Understanding Center Data

Reading Your SRTR Report

The Scientific Registry of Transplant Recipients (SRTR) publishes Program-Specific Reports (PSRs) for every transplant center in the United States. These reports are the primary way to compare center performance using standardized metrics.

Key elements of a center-level SRTR report:

Wait Times Median time from listing to transplant at that center, broken down by organ type and blood type.
Patient Survival 1-year and 3-year post-transplant survival rates compared to expected national averages.
Graft Survival How long transplanted organs continue functioning, compared to the national benchmark.
Transplant Volume Number of transplants performed per year. Higher volume often correlates with better outcomes.
Organ Offer Acceptance How often a center accepts organ offers versus declining them. Higher acceptance can mean shorter wait times.
Waitlist Outcomes Rates of transplant, death, and removal from the waitlist compared to national expectations.

SRTR reports rate each center as performing "better than expected," "as expected," or "worse than expected" compared to a risk-adjusted national average. No single metric tells the full story, so it is important to consider all dimensions together and discuss the data with your transplant team.

Post-Transplant Medications & Recovery

After transplant, you will take immunosuppressant medications for the rest of your life to prevent your body from rejecting the new organ. Understanding these medications is essential.

Common Immunosuppressants
  • Tacrolimus (Prograf) — The most widely used anti-rejection drug. Requires regular blood level monitoring. Side effects may include tremor, high blood pressure, and kidney strain.
  • Mycophenolate (CellCept/Myfortic) — Suppresses immune cell proliferation. Common side effects include GI issues (nausea, diarrhea). Take on schedule.
  • Prednisone — A corticosteroid used at higher doses initially, then tapered over months. Side effects include weight gain, mood changes, bone thinning, and elevated blood sugar.
  • Cyclosporine (Neoral) — Alternative to tacrolimus for some patients. Requires blood level monitoring. Can affect kidney function and blood pressure.
  • Sirolimus/Everolimus — mTOR inhibitors sometimes used as alternatives. May have different side effect profiles.
Medication Adherence

Missing even a few doses of immunosuppressants can trigger acute rejection. Adherence strategies include:

  • Set phone alarms for every dose
  • Use a pill organizer to track daily/weekly doses
  • Keep a backup supply when traveling
  • Never skip or adjust doses without your transplant team's guidance
  • Report any side effects — your team can often adjust the regimen
Signs of Rejection

Contact your transplant team immediately if you experience:

  • Fever above 100.4 F (38 C)
  • Unusual fatigue or malaise
  • Pain or swelling near the transplant site
  • Decreased urine output (kidney) or jaundice (liver)
  • Shortness of breath (heart or lung)
  • Unexplained weight gain (fluid retention)

Regular lab work and protocol biopsies help detect rejection early, even before symptoms appear.

Lifestyle After Transplant
  • Sun protection: Immunosuppression increases skin cancer risk. Use SPF 30+, wear protective clothing, and get annual skin checks.
  • Diet: Avoid raw/undercooked foods initially. Maintain a balanced diet; some medications affect blood sugar and cholesterol.
  • Exercise: Gradually resume activity as approved by your team. Most patients can return to normal activity within 3-6 months.
  • Infection prevention: Wash hands frequently, avoid sick contacts, stay up to date on approved vaccinations (no live vaccines).
  • Mental health: Post-transplant depression and anxiety are common. Seek support from your team, counselors, or peer groups.

For caregiver guidance during recovery, see Caregiver Resources. Track your recovery progress with our Checklist.